FL

Fredrik Ljungström

Description

Fredrik Ljungström

Investor Profile

Fredrik Ljungström has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Debt Financing, Series A rounds (top funding stages).
  • Majority of deals are located in Sweden.
  • Strong thematic focus on Biopharma, Biotechnology, Medical.

Stage Focus

  • Debt Financing (50%)
  • Series A (50%)

Country Focus

  • Sweden (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fredrik Ljungström frequently co-invest with?

Co-Investments: 1
Karolinska
Europe, Stockholms Lan, Sweden, Solna
Co-Investments: 1
Industrifonden
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
Pureos Bioventures
Europe, Zurich, Switzerland, Küsnacht
Co-Investments: 1
Sound Bioventures
Europe, Skane Lan, Sweden, Malmö
Co-Investments: 1
Flerie Invest
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1

Which angels does Fredrik Ljungström often collaborate with?

Shared Deals: 2

What are some of recent deals done by Fredrik Ljungström?

AnaCardio

Solna, Stockholms Lan, Sweden

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

BiopharmaBiotechnologyMedical
Series AJan 9, 2025
Amount Raised: $18,379,535
AnaCardio

Solna, Stockholms Lan, Sweden

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

BiopharmaBiotechnologyMedical
Debt FinancingFeb 3, 2022
Amount Raised: $3,626,423